ARCHIVES

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

This article is from The Cancer Letter archive.

Vol. 33 No. 04 | February 2, 2007

Download PDF Visit The Full Archive

Related Articles

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

CPSC Relies On NCI Findings For New Policy

July 21, 1978

A.D. Little Gets 42.4 Million Contract Award

May 2, 1975